Nevertheless, the changes induced by TREM2R47H and APOE4 show a common impairment in activating the human-specific HLA (rather than DAM) transcriptional program and together suggest that the HLA response to Aβ plaques might be a beneficial aspect of the response of human microglia to AD pathology (Fig. 7h). This evidence concerns the gene APOE and Alzheimer disease.